Seaside Therapeutics Secures $30,000,000 New Round

  • Feed Type
  • Date
  • Company Name
    Seaside Therapeutics
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Seaside founders understand the toll that brain development disorders, including autism and mental retardation, take on families and share the sense of frustration that effective therapeutics are still not available despite recent scientific advances. Seaside Therapeutics was founded to fill this void and to develop potential treatments for these underserved populations by translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The financing will be used to fund the Company’s pipeline of novel therapeutic candidates to correct or improve the course of those who suffer these disorders.
  • M&A Terms
  • Venture Investor

Trending on Xconomy